SkinBioTherapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 15

Employees

  • Stock Symbol
  • SBTX

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.24
  • (As of Friday Closing)

SkinBioTherapeutics General Information

Description

SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

Contact Information

Website
www.skinbiotherapeutics.com
Formerly Known As
Skinbiotix, Skinbiotix Ltd
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • The Core
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5TF
  • England, United Kingdom
+44 0191
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Stock Exchange
LON
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • The Core
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5TF
  • England, United Kingdom
+44 0191

SkinBioTherapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SkinBioTherapeutics Stock Performance

As of 13-Jun-2025, SkinBioTherapeutics’s stock price is $0.24. Its current market cap is $54.5M with 232M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $54.5M 232M 1.22M -$0.02

SkinBioTherapeutics Financials Summary

As of 31-Dec-2024, SkinBioTherapeutics has a trailing 12-month revenue of $3.42M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 30-Jun-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022
EV 53,051 18,883 26,503 34,423
Revenue 3,423 1,522 159 99
EBITDA (2,890) (3,436) (3,543) (3,912)
Net Income (3,291) (3,621) (3,410) (3,713)
Total Assets 9,156 6,596 3,272 3,742
Total Debt 1,288 1,036 127 155
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SkinBioTherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SkinBioTherapeutics‘s full profile, request access.

Request a free trial

SkinBioTherapeutics Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

SkinBioTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202213726-D0 Compositions and uses thereof Inactive 20-Sep-2022
AU-2023345958-A1 Compositions and uses thereof Pending 20-Sep-2022
GB-201807576-D0 Compositions and uses thereof Inactive 09-May-2018
US-20210244779-A1 Compositions and uses thereof Active 09-May-2018
EP-3790566-A1 Compositions and uses thereof Pending 09-May-2018 A61K35/747
To view SkinBioTherapeutics’s complete patent history, request access »

SkinBioTherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SkinBioTherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SkinBioTherapeutics‘s full profile, request access.

Request a free trial

SkinBioTherapeutics Acquisitions (2)

SkinBioTherapeutics’s most recent deal was a Merger/Acquisition with Bio-Tech Solutions for . The deal was made on 11-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bio-Tech Solutions 11-Oct-2024 Merger/Acquisition Personal Products
Dermatonics 26-Jan-2024 Merger/Acquisition Personal Products
To view SkinBioTherapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

SkinBioTherapeutics Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Dermatonics St Ives, United Kingdom 2008
Bio-Tech Solutions Driffield, United Kingdom 2002

SkinBioTherapeutics FAQs

  • When was SkinBioTherapeutics founded?

    SkinBioTherapeutics was founded in 2015.

  • Where is SkinBioTherapeutics headquartered?

    SkinBioTherapeutics is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of SkinBioTherapeutics?

    SkinBioTherapeutics has 15 total employees.

  • What industry is SkinBioTherapeutics in?

    SkinBioTherapeutics’s primary industry is Personal Products.

  • Is SkinBioTherapeutics a private or public company?

    SkinBioTherapeutics is a Public company.

  • What is SkinBioTherapeutics’s stock symbol?

    The ticker symbol for SkinBioTherapeutics is SBTX.

  • What is the current stock price of SkinBioTherapeutics?

    As of 13-Jun-2025 the stock price of SkinBioTherapeutics is $0.24.

  • What is the current market cap of SkinBioTherapeutics?

    The current market capitalization of SkinBioTherapeutics is $54.5M.

  • What is SkinBioTherapeutics’s current revenue?

    The trailing twelve month revenue for SkinBioTherapeutics is $3.42M.

  • What is SkinBioTherapeutics’s annual earnings per share (EPS)?

    SkinBioTherapeutics’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »